170 related articles for article (PubMed ID: 16317298)
1. Gemcitabine-related radiation recall in a patient with pancreatic cancer.
Saif MW; Sellers S; Russo S
Anticancer Drugs; 2006 Jan; 17(1):107-11. PubMed ID: 16317298
[TBL] [Abstract][Full Text] [Related]
2. Radiation recall gastritis secondary to erlotinib in a patient with pancreatic cancer.
Graziani C; Hegde S; Saif MW
Anticancer Res; 2014 Dec; 34(12):7339-43. PubMed ID: 25503169
[TBL] [Abstract][Full Text] [Related]
3. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
Saif MW; Black G; Johnson M; Russo S; Diasio R
Cancer Chemother Pharmacol; 2006 Dec; 58(6):771-5. PubMed ID: 16552574
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-related radiation recall preferentially involves internal tissue and organs.
Friedlander PA; Bansal R; Schwartz L; Wagman R; Posner J; Kemeny N
Cancer; 2004 May; 100(9):1793-9. PubMed ID: 15112258
[TBL] [Abstract][Full Text] [Related]
5. Radiation recall gastritis secondary to combination of gemcitabine and erlotinib in pancreatic cancer and response to PPI - a case report.
Choi SJ; Kim HJ; Kim JS; Bak YT; Kim JS
BMC Cancer; 2016 Aug; 16():588. PubMed ID: 27484349
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-induced radiation recall.
Jeter MD; Jänne PA; Brooks S; Burstein HJ; Wen P; Fuchs CS; Loeffler JS; Devlin PM; Salgia R
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):394-400. PubMed ID: 12023144
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-induced rectus abdominus radiation recall.
Fakih MG
JOP; 2006 May; 7(3):306-10. PubMed ID: 16685112
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas.
Pipas JM; Mitchell SE; Barth RJ; Vera-Gimon R; Rathmann J; Meyer LP; Wagman RS; Lewis LD; McDonnell C; Colacchio TA; Perez RP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1317-22. PubMed ID: 11483344
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.
Lin LL; Picus J; Drebin JA; Linehan DC; Solis J; Strasberg SM; Tan B; Thorstad WL; Myerson R
Am J Clin Oncol; 2005 Jun; 28(3):234-41. PubMed ID: 15923794
[TBL] [Abstract][Full Text] [Related]
10. Radiation recall phenomenon secondary to bevacizumab in a patient with pancreatic cancer.
Saif MW; Ramos J; Knisely J
JOP; 2008 Nov; 9(6):744-7. PubMed ID: 18981558
[No Abstract] [Full Text] [Related]
11. Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.
Crane CH; Winter K; Regine WF; Safran H; Rich TA; Curran W; Wolff RA; Willett CG
J Clin Oncol; 2009 Sep; 27(25):4096-102. PubMed ID: 19636002
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer.
Shaib W; Lansigan F; Cornfeld D; Syrigos K; Saif MW
JOP; 2008 Nov; 9(6):708-14. PubMed ID: 18981552
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
Pentsova E; Liu A; Rosenblum M; O'Reilly E; Chen X; Hormigo A
J Neurooncol; 2012 Jan; 106(1):15-21. PubMed ID: 21811892
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal bleeding associated with concurrent capecitabine and radiotherapy in patients with pancreatic cancer.
Saif MW; Moody JS; Russo SM
JOP; 2005 Jul; 6(4):325-33. PubMed ID: 16006682
[TBL] [Abstract][Full Text] [Related]
15. A Case of Severe Rectal Hemorrhage Possibly Caused by Radiation Recall after Administration of Gemcitabine.
Nishimoto K; Akise Y; Miyazawa M; Kutsuki S; Hashimoto S; Uchida A
Keio J Med; 2016; 65(1):16-20. PubMed ID: 27040885
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head.
Crane CH; Antolak JA; Rosen II; Forster KM; Evans DB; Janjan NA; Charnsangavej C; Pisters PW; Lenzi R; Papagikos MA; Wolff RA
Int J Gastrointest Cancer; 2001; 30(3):123-32. PubMed ID: 12540024
[TBL] [Abstract][Full Text] [Related]
17. Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study.
Beane JD; Griffin KF; Levy EB; Pandalai P; Wood B; Abi-Jaoudeh N; Beresnev T; Shutack Y; Webb CC; Avital I; Rudloff U
Invest New Drugs; 2015 Feb; 33(1):109-18. PubMed ID: 25236592
[TBL] [Abstract][Full Text] [Related]
18. [Three-dimensional conformal radiation therapy concurrent with full dose Gemcitabine for locally advanced inoperable pancreatic cancer].
Mendlovic S; Symon Z; Kundel Y; Rabin T; Catane R; Pfeffer R
Harefuah; 2008 May; 147(5):384-7, 480. PubMed ID: 18770957
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer.
Lipton A; Campbell-Baird C; Witters L; Harvey H; Ali S
J Clin Gastroenterol; 2010 Apr; 44(4):286-8. PubMed ID: 20216081
[TBL] [Abstract][Full Text] [Related]
20. [Concurrent chemoradiotherapy using full-dose gemcitabine for patients with unresectable pancreatic cancer].
Yamazaki H; Nishiyama K; Koizumi M
Nihon Igaku Hoshasen Gakkai Zasshi; 2004 May; 64(4):216-9. PubMed ID: 15211883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
